VOYA Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.2K Sell
20,221
-709
-3% -$2.4K ﹤0.01% 2265
2025
Q4
$68K Hold
20,930
﹤0.01% 2307
2025
Q3
$60.1K Sell
20,930
-13,846
-40% -$35.4K ﹤0.01% 2368
2025
Q2
$83.8K Buy
34,776
+3,462
+11% +$7.28K ﹤0.01% 2522
2025
Q1
$69.2K Sell
31,314
-315,409
-91% -$1.25M ﹤0.01% 2502
2024
Q4
$1.89M Buy
346,723
+267,485
+338% +$1.72M ﹤0.01% 1321
2024
Q3
$658K Sell
79,238
-38,193
-33% -$330K ﹤0.01% 1850
2024
Q2
$841K Sell
117,431
-71,386
-38% -$616K ﹤0.01% 1718
2024
Q1
$1.64M Buy
188,817
+109,497
+138% +$741K ﹤0.01% 1423
2023
Q4
$520K Sell
79,320
-957
-1% -$6.18K ﹤0.01% 2057
2023
Q3
$803K Sell
80,277
-859
-1% -$9.43K ﹤0.01% 1764
2023
Q2
$1.01M Sell
81,136
-75,080
-48% -$1.01M ﹤0.01% 1661
2023
Q1
$2.19M Buy
156,216
+4,683
+3% +$67.3K ﹤0.01% 1318
2022
Q4
$2.17M Buy
151,533
+84,274
+125% +$1.33M ﹤0.01% 1288
2022
Q3
$1.72M Buy
67,259
+20,243
+43% +$508K ﹤0.01% 1383
2022
Q2
$1.34M Sell
47,016
-6,397
-12% -$203K ﹤0.01% 1265
2022
Q1
$1.88M Sell
53,413
-1,009
-2% -$33.8K ﹤0.01% 1141
2021
Q4
$2.28M Buy
54,422
+21,769
+67% +$882K ﹤0.01% 1102
2021
Q3
$1.6M Buy
32,653
+7,753
+31% +$378K ﹤0.01% 1291
2021
Q2
$1.04M Buy
24,900
+6,214
+33% +$241K ﹤0.01% 1600
2021
Q1
$666K Buy
+18,686
New +$619K ﹤0.01% 1855

Other funds holding MRVI

VOYA Investment Management's MRVI Position: Q1 2026 in Review

VOYA Investment Management reduced its Maravai LifeSciences (MRVI) stake by 3.4% in Q1 2026, selling an estimated $2.4K and leaving 20,221 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2265.

VOYA Investment Management first reported a position in MRVI in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.28M in Q4 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • VOYA Investment Management held 20,221 shares of Maravai LifeSciences worth $57.2K as of Q1 2026.
  • VOYA Investment Management sold 709 Maravai LifeSciences shares in Q1 2026, an estimated $2.4K.
  • Maravai LifeSciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2265 holding.
  • VOYA Investment Management first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 21 quarters since.
  • VOYA Investment Management's Maravai LifeSciences position peaked at $2.28M in Q4 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.